Lorence H. Kim, Chief Financial Officer at Moderna, Inc. (MRNA), sold 237,226 shares at $20.39 ($4.7M) on 2019-12-06, disclosed to the SEC on 2019-12-09.
Open-market sale of $4.7M MRNA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.34 | 89,698 | $1.7M | 36.6% |
| 2 | $20.39 | 147,528 | $3.0M | 63.4% |
| Total | $19.99 avg | 237,226 | $4.7M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-25 | $1.0M | — | Filing → |
| COWN | BUY | 2022-02-28 | $901K | — | Filing → |
| MRNA | SELL | 2020-06-04 | $14.1M | — | Filing → |